BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,250,000 | -19.4% | 271,597 | -2.7% | 0.05% | -9.8% |
| Q2 2023 | $12,713,000 | +7.5% | 279,035 | -4.3% | 0.05% | +4.1% |
| Q1 2023 | $11,821,000 | -22.6% | 291,448 | -2.7% | 0.05% | -25.8% |
| Q4 2022 | $15,268,000 | -5.3% | 299,544 | +0.1% | 0.07% | -9.6% |
| Q3 2022 | $16,124,000 | -15.6% | 299,361 | +0.6% | 0.07% | -9.9% |
| Q2 2022 | $19,107,000 | -17.1% | 297,479 | +0.0% | 0.08% | 0.0% |
| Q1 2022 | $23,062,000 | -12.1% | 297,418 | -2.6% | 0.08% | -8.0% |
| Q4 2021 | $26,225,000 | +3.9% | 305,506 | -2.7% | 0.09% | -2.2% |
| Q3 2021 | $25,246,000 | -1.2% | 313,887 | -1.1% | 0.09% | 0.0% |
| Q2 2021 | $25,541,000 | -6.7% | 317,274 | -2.2% | 0.09% | -17.4% |
| Q1 2021 | $27,372,000 | +13.5% | 324,549 | +8.0% | 0.11% | +0.9% |
| Q4 2020 | $24,109,000 | +7.0% | 300,459 | +7.2% | 0.11% | -12.2% |
| Q3 2020 | $22,536,000 | -6.1% | 280,232 | +0.5% | 0.12% | -10.2% |
| Q2 2020 | $23,999,000 | +7.2% | 278,734 | +1.1% | 0.14% | -11.0% |
| Q1 2020 | $22,383,000 | -20.0% | 275,685 | -17.7% | 0.15% | +6.2% |
| Q4 2019 | $27,995,000 | -1.0% | 334,791 | +3.6% | 0.14% | -4.0% |
| Q3 2019 | $28,280,000 | +7.6% | 323,308 | +0.8% | 0.15% | +7.1% |
| Q2 2019 | $26,275,000 | -6.0% | 320,816 | -6.7% | 0.14% | -3.4% |
| Q1 2019 | $27,956,000 | +23.6% | 343,820 | +0.1% | 0.15% | +10.6% |
| Q4 2018 | $22,609,000 | -16.7% | 343,498 | -2.4% | 0.13% | -1.5% |
| Q3 2018 | $27,143,000 | -45.7% | 352,093 | -48.0% | 0.13% | -47.0% |
| Q2 2018 | $49,981,000 | +14.3% | 676,881 | +0.7% | 0.25% | +11.0% |
| Q1 2018 | $43,719,000 | +63.2% | 672,185 | +62.2% | 0.23% | +74.0% |
| Q4 2017 | $26,789,000 | -0.6% | 414,430 | -3.5% | 0.13% | -6.4% |
| Q3 2017 | $26,949,000 | -51.7% | 429,461 | -53.4% | 0.14% | -8.5% |
| Q2 2017 | $55,818,000 | +85.2% | 921,986 | +58.6% | 0.15% | -9.5% |
| Q1 2017 | $30,139,000 | +3.2% | 581,168 | -0.4% | 0.17% | +3.0% |
| Q4 2016 | $29,205,000 | -0.2% | 583,395 | -5.1% | 0.16% | -8.9% |
| Q3 2016 | $29,267,000 | +51.3% | 614,846 | +43.7% | 0.18% | +44.0% |
| Q2 2016 | $19,342,000 | +8.6% | 427,741 | -1.3% | 0.12% | +6.8% |
| Q1 2016 | $17,808,000 | +9.0% | 433,489 | +1.2% | 0.12% | +17.0% |
| Q4 2015 | $16,336,000 | +15.5% | 428,203 | -0.5% | 0.10% | +11.1% |
| Q3 2015 | $14,141,000 | -52.9% | 430,470 | +0.2% | 0.09% | -48.0% |
| Q2 2015 | $30,042,000 | +4.2% | 429,606 | +2.1% | 0.17% | +4.8% |
| Q1 2015 | $28,819,000 | -5.9% | 420,720 | +0.7% | 0.16% | -7.3% |
| Q4 2014 | $30,633,000 | +2.3% | 417,976 | +0.2% | 0.18% | +0.6% |
| Q3 2014 | $29,930,000 | -5.3% | 417,022 | -4.6% | 0.18% | -0.6% |
| Q2 2014 | $31,599,000 | -1.7% | 437,056 | +0.0% | 0.18% | -4.8% |
| Q1 2014 | $32,156,000 | -2.2% | 437,025 | -7.6% | 0.19% | +6.2% |
| Q4 2013 | $32,884,000 | +10.9% | 472,806 | +4.7% | 0.18% | +10.7% |
| Q3 2013 | $29,664,000 | -9.6% | 451,568 | -4.7% | 0.16% | -14.5% |
| Q2 2013 | $32,818,000 | – | 473,774 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |